UH CANCER CENTER RESEARCHERS PICK UP PROVISIONAL PATENT FOR CANCER FINDING

Written by: Lorin Eleni Gill, Reporter for Pacific Business News, May 6, 2016 @ 2:19pm University of Hawaii Cancer Center researchers have secured a provisional patent that will assist in cancer research and potentially help doctors catch cancer earlier. Lana Garmire, an assistant professor in the Cancer Epidemiology Program, led the study using “big data,” […]

UH CANCER RESEARCHERS RECEIVE $3M FROM U.S. DEFENSE DEPARTMENT

Written by: Lorin Eleni Gill, Biz Journals, March 30, 2016 @ 12:29pm HST Researchers at the University of Hawaii Cancer Center and John A. Burns School of Medicine in Honolulu have been awarded $3 million by the Department of Defense for mesothelioma-related research projects. The cancer research grants, which focus on asbestos-related malignant mesothelioma, were […]

UH BLADDER CANCER DRUG SHOWS PROMISE

Written by: Kristen Consillio, Star Advertiser, November 23, 2015 @ 1:30am The University of Hawaii Cancer Center is a step closer to getting federal approval for a new bladder cancer drug. The drug, an interleukin 15 superagonist complex combined with Bacillus Calmette-Guerin, or BCG, currently in clinical trials, is expected to be more effective for […]

NEW KIND OF ‘DESIGNER’ IMMUNE CELLS CLEAR BABY’S LEUKEMIA

Written by: Kate Kelland, Reuters.com, November 6, 2015 @ 9:58am EST(http://www.reuters.com/article/2015/11/06/us-health-leukaemia-cellectis-idUSKCN0SU2PO20151106) A baby whom doctors thought almost certain to die has been cleared of a previously incurable leukemia in the first human use of an “off-the-shelf” cell therapy from Cellectis that creates designer immune cells. One-year-old Layla had run out of all other treatment options […]

NEW TREATMENT FOR MELANOMA GETS FDA APPROVAL

Written by: Robert Preidt, HealthDay.com, October 28, 2015(http://consumer.healthday.com/cancer-information-5/skin-cancer-news-108/novel-treatment-for-melanoma-shows-promise-in-early-trial-704669.html) A genetically engineered cold sore virus that “blows up” melanoma tumors has been approved by the U.S. Food and Drug Administration to help treat the deadly skin cancer. Imlygic (talimogene laherparepvec), a first-of-its-kind therapy, showed promise against lesions in the skin and lymph nodes in an early […]

NOVOCURE: TTFIELDS THERAPY

Novocure is a global, commercial-stage oncology company that is pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields, with the use of electric fields. Novocure is headquartered in Jersey Isle, and operates in Portsmouth, NH and New York, NY. The company also has offices in Switzerland, Germany and Japan, and a […]

QUEEN’S TO JOIN ONE OF TOP CANCER NETWORKS

Written by: Kristen Consillio, Star Advertiser, September 18, 2015 @ 1:30am The Queen’s Medical Center said it has become a member of the MD Anderson Cancer Network, part of the University of Texas MD Anderson Cancer Center, ranked No. 1 in the “Best Hospitals” survey published annually by U.S. News & World Report. The organizations, […]

2017 DIRECTORS MEETING

Drew Santos represented Cooling Cancer and Admor HVAC Products at the University of Hawaii Cancer Center (UHCC) Director’s Circle meeting held on November 8, 2017. Dr. Randall Holcombe, Director of the Center led the meeting that reviewed the State of the Cancer Center, Current Budget, Future Direction, Clinical Trials, Community Engagement, National Cancer Institute Accreditation […]

KOMEN RACE FOR THE CURE HAWAII

We all know several incredible women who are breast cancer survivors. Each one of them is a gift and the reason why we must help support breast cancer research and patients. CoolingCancer started its first team to participate in the 2017 Susan G. Komen’s Race for the Cure® and joined the fight against breast cancer […]